Atea Pharmaceuticals, Inc. (AVIR) Insider Trading Disclosures
Atea Pharmaceuticals, Inc. (AVIR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AVIR
CIK: 1593899
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: MA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerJennifer Plotnick
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-06 | — | SCHEDULE 13G Filing | 0001214659-26-012604 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-347021 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-346888 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279728 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279726 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279723 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279721 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279719 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279718 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279720 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | 4 | 0001193125-26-279717 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001193125-26-277639 | View SEC Doc Filr Page |
| 4/A | 2026-05-21 | 2026-05-18 | 4/A | 0001193125-26-235039 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | 4 | 0001193125-26-232612 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-219678 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-219507 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001112 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-27 | — | DEFA14A | 0001193125-26-182340 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-18 | DEF 14A | 0001193125-26-182293 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-000786 | View SEC Doc Filr Page |
| 4 | 2026-03-13 | 2026-03-11 | 4 | 0001193125-26-106547 | View SEC Doc Filr Page |
| 10-K | 2026-03-05 | 2025-12-31 | 10-K | 0001193125-26-094159 | View SEC Doc Filr Page |
| 8-K | 2026-03-05 | 2026-03-05 | 8-K | 0001193125-26-093961 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-09 | — | SCHEDULE 13G Filing | 0001373604-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-02-03 | 2026-01-31 | 4 | 0001193125-26-036281 | View SEC Doc Filr Page |